[Form 4] Ondas Holdings Inc. Insider Trading Activity
Rhea-AI Filing Summary
Ondas Holdings Inc. (ONDS) reported a non-derivative compensation grant to director Randy Seidl: 15,645 Restricted Stock Units (RSUs) were granted on 08/11/2025. Each RSU is a contingent right to receive one share of the company's common stock, and the award was approved in connection with the Compensation Committee's adoption of an Amended and Restated Non-Employee Director Compensation Policy referenced as Exhibit 10.4 in the issuer's quarterly report for the period ended June 30, 2025.
The RSUs carry a vesting schedule that spreads payouts across late 2025 and through 2026, specifically portions vesting in the third and fourth quarters of 2025 and quarterly through 2026. The reported grant uses a $0 price basis for the RSUs, indicating they are awards rather than purchases.
Positive
- None.
Negative
- None.
Insights
TL;DR Director Randy Seidl received 15,645 RSUs tied to a revised non-employee director compensation policy; vesting stretches through 2026.
The grant is a standard non-employee director compensation event reflecting an approved policy update rather than a market transaction by the director. The award quantity, 15,645 RSUs, is clearly specified and converts one-for-one into common shares upon vesting. The staged vesting schedule aligns incentives over multiple quarters, and the award is reported as direct beneficial ownership. From a governance perspective, the disclosure is complete in identifying the instrument, link to the committee approval and the vesting cadence, allowing investors to assess timing of potential share issuance.
TL;DR This Form 4 documents a director RSU grant of 15,645 units with quarterly vesting through 2026; impact appears routine and non-material on its face.
The filing documents a 15,645 RSU grant awarded under the amended non-employee director compensation policy and reported as direct beneficial ownership. The disclosure includes a granular vesting schedule: 1,561 RSUs vest in Q3 2025, 2,817 in Q4 2025, 2,816 in Q1 2026, and 2,817 in each of Q2–Q4 2026, which clarifies when shares may be issued. There is no cash purchase price and the RSUs convert to common stock on vesting. For investors, this is a routine compensation disclosure rather than an active buy or sell by the director.